In obesity, IL-6 elevation initially drives M1-like adipose tissue macrophages (ATMs), contributing to insulin resistance [15], but sustained IL-6/STAT3 activation favors M2-like phenotypes with immunosuppressive features [16]. The gene discussed is IL6; the disease is obesity disorder.